Getting the best out of faecal immunochemical tests and faecal calprotectin.
作者信息
Chuter Charlotte, Keding Ada, Holmes Hayden, Turnock Daniel, Turvill James
机构信息
Gastroenterology, York Teaching Hospital NHS Foundation Trust, York, North Yorkshire, UK.
Health Sciences, University of York, York, North Yorkshire, UK.
出版信息
Frontline Gastroenterol. 2019 Dec 24;11(5):414-416. doi: 10.1136/flgastro-2019-101381. eCollection 2020.
Abstract
摘要
相似文献
1
Getting the best out of faecal immunochemical tests and faecal calprotectin.充分利用粪便免疫化学检测和粪便钙卫蛋白
Frontline Gastroenterol. 2019 Dec 24;11(5):414-416. doi: 10.1136/flgastro-2019-101381. eCollection 2020.
2
Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.基层医疗中结直肠癌和炎症性肠病的诊断：粪便血红蛋白、粪便钙卫蛋白、贫血及缺铁检测的效用。一项前瞻性研究。
Scand J Gastroenterol. 2017 Jan;52(1):69-75. doi: 10.1080/00365521.2016.1228120. Epub 2016 Sep 14.
3
Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.粪便钙卫蛋白作为区分炎症性肠病和肠易激综合征的新型生物标志物。
Mol Med Rep. 2014 Jul;10(1):522-6. doi: 10.3892/mmr.2014.2180. Epub 2014 Apr 24.
4
Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.粪便血红蛋白和粪便钙卫蛋白作为肠道症状患者肠道疾病的指标，这些患者因肠道症状就诊于初级保健机构。
Gut. 2016 Sep;65(9):1463-9. doi: 10.1136/gutjnl-2015-309579. Epub 2015 Aug 20.
5
Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.两种免疫分析法检测粪便钙卫蛋白在炎症性肠病诊断中的比较：（分析前）和诊断性能特征。
Clin Chem Lab Med. 2014 Mar;52(3):391-7. doi: 10.1515/cclm-2013-0699.
6
Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.钙卫蛋白水平能否识别肠易激综合征患者中的一个亚组？一项前瞻性研究的结果。
United European Gastroenterol J. 2017 Mar;5(2):261-269. doi: 10.1177/2050640616650062. Epub 2016 Jun 23.
7
Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation.比较无创生物标志物粪便 BAFF、钙卫蛋白和 FOBT 在鉴别 IBS 与 IBD 以及评估肠道炎症中的作用。
Sci Rep. 2017 Jun 1;7(1):2669. doi: 10.1038/s41598-017-02835-5.
8
Faecal Calprotectin.粪便钙卫蛋白
Clin Biochem Rev. 2018 Aug;39(3):77-90.
9
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.粪便S100A12作为区分炎症性肠病和肠易激综合征的非侵入性标志物。
Gut. 2007 Dec;56(12):1706-13. doi: 10.1136/gut.2006.113431. Epub 2007 Aug 3.
10
Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease.用于检测结肠炎性肠病疾病活动的快速粪便检测
Eur J Clin Invest. 2016 Oct;46(10):825-32. doi: 10.1111/eci.12660. Epub 2016 Sep 6.
引用本文的文献
1
Research progress on the diagnostic value of fecal calprotectin in colorectal tumors.粪便钙卫蛋白在结直肠肿瘤诊断价值中的研究进展
Front Med (Lausanne). 2025 Jul 9;12:1626197. doi: 10.3389/fmed.2025.1626197. eCollection 2025.
2
Biomarkers to Detect Early-Stage Colorectal Cancer.用于检测早期结直肠癌的生物标志物。
Biomedicines. 2022 Jan 25;10(2):255. doi: 10.3390/biomedicines10020255.
本文引用的文献
1
Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.疑似结直肠癌患者进行一两次粪便血红蛋白和钙卫蛋白检测的诊断准确性。
Scand J Gastroenterol. 2018 Dec;53(12):1526-1534. doi: 10.1080/00365521.2018.1539761. Epub 2019 Jan 8.
2
Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care Pathway.约克粪便钙卫蛋白护理路径的临床及成本效益评估。
Frontline Gastroenterol. 2018 Oct;9(4):285-294. doi: 10.1136/flgastro-2018-100962. Epub 2018 Jun 7.
3
High negative predictive value of a normal faecal calprotectin in patients with symptomatic intestinal disease.粪便钙卫蛋白正常对有症状肠道疾病患者具有较高的阴性预测价值。
Frontline Gastroenterol. 2012 Jan;3(1):21-28. doi: 10.1136/flgastro-2011-100011. Epub 2011 Sep 19.
4
Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.疑似结直肠癌患者的粪便钙卫蛋白：一项诊断准确性研究。
Br J Gen Pract. 2016 Jul;66(648):e499-506. doi: 10.3399/bjgp16X685645. Epub 2016 Jun 6.
5
Evaluation of a faecal calprotectin care pathway for use in primary care.用于初级保健的粪便钙卫蛋白护理路径评估。
Prim Health Care Res Dev. 2016 Sep;17(5):428-36. doi: 10.1017/S1463423616000049. Epub 2016 Feb 22.
6
Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.使用粪便免疫化学检测血红蛋白有助于对下腹部症状患者进行调查。
Clin Chem Lab Med. 2016 Apr;54(4):595-602. doi: 10.1515/cclm-2015-0617.
7
Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.粪便血红蛋白和粪便钙卫蛋白作为肠道症状患者肠道疾病的指标，这些患者因肠道症状就诊于初级保健机构。
Gut. 2016 Sep;65(9):1463-9. doi: 10.1136/gutjnl-2015-309579. Epub 2015 Aug 20.
8
Low faecal haemoglobin concentration potentially rules out significant colorectal disease.粪便血红蛋白浓度低可能排除了重大结直肠疾病。
Colorectal Dis. 2013 Mar;15(3):e151-9. doi: 10.1111/codi.12087.
Zotero 插件